Notice: This company has been marked as potentially delisted and may not be actively trading. Neuralstem (CUR) News Today Add Compare Share Share Headlines Stock AnalysisCompetitorsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Aguas Da Curia Share Price (CUR.LS)November 25, 2023 | lse.co.ukXAUUSD:CUR Gold Spot PriceAugust 22, 2023 | seekingalpha.com4 Biotech Stocks Under $10 Moving HigherJuly 20, 2023 | thestreet.comXPTUSD:CUR Platinum Spot PriceJune 28, 2023 | seekingalpha.comXAUUSD:CURMay 16, 2023 | seekingalpha.comNovAccess Global : Announces Fireside Chat with Board Member Perspectives - Marketscreener.comOctober 20, 2022 | marketscreener.comAnti-inflammatory compound supercharges stem cell stroke treatment - Yahoo NewsOctober 12, 2022 | news.yahoo.comBest microscope photos of 2022 reveal stunning hidden world around us - Business InsiderOctober 11, 2022 | businessinsider.comStem Cell Manufacturing Global Market Report 2022: Widespread Product Utilization in Effective Disease Ma - BenzingaOctober 11, 2022 | benzinga.comAruna Bio Announces Presentation on Neural Exosome Treatment Opportunities and Lead Program, AB126 at Exosome Based Therapeutic Development Summit - GlobeNewswireOctober 6, 2022 | globenewswire.comBOLDEN THERAPEUTICS RECEIVES $406,466 SBIR GRANT FROM THE NATIONAL INSTITUTE ON AGING TO SUPPORT DEVELOPMENT OF ANTISENSE OLIGONUCLEOTIDES TO PROMOTE NEUROGENESIS - StreetInsider.comSeptember 16, 2022 | streetinsider.comBGI-led Research Builds the World's First Spatiotemporal Map of Brain Regeneration - PR NewswireSeptember 2, 2022 | prnewswire.comGlobal Recurrent Glioblastoma Pipeline Insight | Clinical Trials Research Report 2022 by DelveInsight - GlobeNewswireAugust 23, 2022 | globenewswire.comHow Scientists Successfully Reversed Alzheimer's in Mice - NewsweekAugust 23, 2022 | newsweek.comDioseve wants to help infertile people with tech that grows egg cells - TechCrunchAugust 22, 2022 | techcrunch.comThe Global Stem Cell Manufacturing Market grew USD 4,378.00 million by 2027, at a CAGR of 12.23%. - Yahoo FinanceAugust 12, 2022 | finance.yahoo.comThe Global Stem Cell Manufacturing Market grew USD 4,378.00 - GlobeNewswireAugust 12, 2022 | globenewswire.comCalidi Biotherapeutics Announces FDA Authorization of IND for a Phase 1 Clinical Trial of NeuroNova in Patients with Recurrent High-Grade Glioma - Yahoo FinanceAugust 4, 2022 | finance.yahoo.comCalidi Biotherapeutics Announces FDA Authorization of IND for a Phase 1 Clinical Trial of NeuroNova in Patients with Recurrent High-Grade Glioma - Business WireAugust 2, 2022 | businesswire.comHow chickenpox virus is linked to onset of Alzheimer's disease - Investing.com IndiaAugust 1, 2022 | in.investing.comCan Inflammation Lead To Cognitive Issues? Past Research Says 'Yes', With Implications For Covid-19 - ForbesJuly 21, 2022 | forbes.comHigh-flying experiment: Do stem cells grow better in space? - ABC NewsJuly 17, 2022 | abcnews.go.comjCyte Announces Appointment of Dr. Stewart Craig as Chief Technology Officer - StreetInsider.comJuly 12, 2022 | streetinsider.comResearch On Flies Provides Hope For Brain Repair - ForbesJuly 11, 2022 | forbes.comStem Cell Assays Market Report 2022-2027: Government Initiatives to Boost Stem Cell Research Present Opportunities - Yahoo FinanceJuly 7, 2022 | finance.yahoo.comThe Albany College of Pharmacy's plans at the Center for Medical Science building - Albany Business Review - The Business JournalsJuly 7, 2022 | bizjournals.comGlobal Stem Cell Assays Market Projected to Reach $4.5 Billion by 2027 - Yahoo Finance UKJuly 6, 2022 | uk.finance.yahoo.comGlobal Stem Cell Assays Market Projected to Reach $4.5 Billion by 2027 - GlobeNewswireJuly 6, 2022 | globenewswire.comStem Cell Assays Market Report 2022-2027: Increasing Awareness About Therapeutic Potency of Stem Cells Driving Growth - ResearchAndMarkets.com - Business WireJuly 5, 2022 | businesswire.comStem Cell Assays Market worth $4.5 billion by 2027 – Exclusive Report by MarketsandMarkets™ - Yahoo FinanceJuly 5, 2022 | finance.yahoo.comAlbany College of Pharmacy and Health Sciences buys Center For Medical Science building - Albany Business Review - The Business JournalsJune 30, 2022 | bizjournals.comBOLDEN THERAPEUTICS RECEIVES $497,500 SBIR GRANT FROM THE NATIONAL INSTITUTE ON AGING TO SUPPORT DEVELOPMENT OF ANTISENSE OLIGONUCLEOTIDES TO PROMOTE NEUROGENESIS - PR NewswireJune 29, 2022 | prnewswire.comStem Cell Assays Market worth $4.5 billion by 2027 - Exclusive Report by MarketsandMarkets™ - Yahoo FinanceJune 21, 2022 | finance.yahoo.comARUNA BIO ANNOUNCES ISSUANCE OF A NEW COMPOSITION OF MATTER PATENT COVERING NEURAL EXOSOMES IN JAPAN - PR NewswireJune 13, 2022 | prnewswire.comChung-Ang University Researchers Use Biomolecule-Loaded Metal-Organic Frameworks Nanopatterns to Aid Artificial Stem Cell Differentiation - PR NewswireJune 10, 2022 | prnewswire.comUTSA awards $4 million to Oskar Fischer Prize recipients for innovative explanations of Alzheimer's disease - Yahoo FinanceJune 8, 2022 | finance.yahoo.comAruna Bio Advances Therapeutic Development for Traumatic Brain Injury - PR NewswireMay 31, 2022 | prnewswire.comLUXA BIO Announces First Participant Dosed in Phase 1/2a Clinical Trial of Adult RPESC-RPE-4W for Dry Age-related Macular Degeneration - Business WireMay 24, 2022 | businesswire.comINTERNATIONAL STEM CELL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - Marketscreener.comMay 13, 2022 | marketscreener.comUnited States to Lead Global Induced Pluripotent Stem Cell (iPSC) Market Growth: Fact.MR Analysis - GlobeNewswireMay 5, 2022 | globenewswire.comGenenta Science (GNTA) Announces Nomination of Mark A. Sirgo as Chair - StreetInsider.comApril 28, 2022 | streetinsider.comARUNA BIO APPOINTS STEPHEN FROM AS CHIEF EXECUTIVE OFFICER - PR NewswireApril 27, 2022 | prnewswire.comGenenta Announces Nomination of Mark A. Sirgo as Chair - Yahoo Finance UKApril 27, 2022 | uk.finance.yahoo.com2022 Lurie Prize in Biomedical Sciences Winners Provide Powerful Contributions to Our Understanding of the Aging Process - PR NewswireApril 14, 2022 | prnewswire.comINTERNATIONAL STEM CELL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) - Marketscreener.comMarch 29, 2022 | marketscreener.comAgeX Therapeutics Reports Fourth Quarter and Annual 2021 Financial Results - Yahoo FinanceMarch 29, 2022 | finance.yahoo.comNOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Changes in Control or Registra - Marketscreener.comMarch 14, 2022 | marketscreener.comKringle Pharma : Files Patent Application for Treatment of Chronic Spinal Cord Injury - Marketscreener.comMarch 11, 2022 | marketscreener.comCalidi Biotherapeutics and Edoc Acquisition Corp. Agree to Merge and Create a Publicly Listed, Clinical-Stage Biotechnology Company Utilizing Stem Cell-Based Platforms to Revolutionize Oncolytic Virotherapies - Yahoo FinanceFebruary 3, 2022 | finance.yahoo.comHow ‘Dormant’ Cells In The Aging Brain Contribute To Cognitive Decline - ForbesFebruary 1, 2022 | forbes.com Get Neuralstem News Delivered to You Automatically Sign up to receive the latest news and ratings for CUR and its competitors with MarketBeat's FREE daily newsletter. Email Address I was wrong. Dead wrong. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. CUR Media Mentions By Week CUR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CUR News Sentiment▼0.000.60▲Average Medical News Sentiment CUR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CUR Articles This Week▼00▲CUR Articles Average Week Get Neuralstem News Delivered to You Automatically Sign up to receive the latest news and ratings for CUR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AIM News APTO News TSBX News BCDA News BCLI News COEP News CERO News EVAX News ONVO News FRTX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CUR) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuralstem, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neuralstem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
